{"entity":{"type":"insider","cik":"0001550395","url":"/insider/0001550395","json_url":"/insider/0001550395.json","name":"ALTSHULER DAVID","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":229,"n_filings":89,"first":"2014-08-01","last":"2025-05-19","span_basis":"filed_date"},"name_variants":[{"name":"ALTSHULER DAVID","source":"filing","n_filings":89,"first_seen":"2014-08-01","last_seen":"2025-05-19"}],"transactions":[{"id":5148251,"accession":"0000875320-25-000201","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-25-000201","line_url":"/filing/0000875320-25-000201#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52.0,"shares_display":"52","price_per_share":424.69,"price_display":"424.69","price_state":"stated","total_value":22083.88,"total_display":"22,083.88","total_whole":"22,084","shares_owned_after":23281.0,"shares_owned_after_display":"23,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-15","filed_date":"2025-05-19","scope":"insider"},{"id":4026587,"accession":"0000875320-25-000152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-25-000152","line_url":"/filing/0000875320-25-000152#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3231.0,"shares_display":"3,231","price_per_share":510.0,"price_display":"510.00","price_state":"stated","total_value":1647810.0,"total_display":"1,647,810.00","total_whole":"1,647,810","shares_owned_after":23281.0,"shares_owned_after_display":"23,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-13","filed_date":"2025-03-17","scope":"insider"},{"id":4090293,"accession":"0000875320-25-000144","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-25-000144","line_url":"/filing/0000875320-25-000144#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3231.0,"shares_display":"3,231","price_per_share":500.0,"price_display":"500.00","price_state":"stated","total_value":1615500.0,"total_display":"1,615,500.00","total_whole":"1,615,500","shares_owned_after":26512.0,"shares_owned_after_display":"26,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider"},{"id":4191813,"accession":"0000875320-25-000139","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-25-000139","line_url":"/filing/0000875320-25-000139#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3231.0,"shares_display":"3,231","price_per_share":490.0,"price_display":"490.00","price_state":"stated","total_value":1583190.0,"total_display":"1,583,190.00","total_whole":"1,583,190","shares_owned_after":29743.0,"shares_owned_after_display":"29,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider"},{"id":5066449,"accession":"0000875320-25-000120","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000120","line_url":"/filing/0000875320-25-000120#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1272.0,"shares_display":"1,272","price_per_share":480.0,"price_display":"480.00","price_state":"stated","total_value":610560.0,"total_display":"610,560.00","total_whole":"610,560","shares_owned_after":32974.0,"shares_owned_after_display":"32,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-02-28","scope":"insider"},{"id":4903613,"accession":"0000875320-25-000101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000101","line_url":"/filing/0000875320-25-000101#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":848.0,"shares_display":"848","price_per_share":480.95,"price_display":"480.95","price_state":"stated","total_value":407845.6,"total_display":"407,845.60","total_whole":"407,846","shares_owned_after":40200.0,"shares_owned_after_display":"40,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-25","filed_date":"2025-02-26","scope":"insider"},{"id":4977322,"accession":"0000875320-25-000099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-25-000099","line_url":"/filing/0000875320-25-000099#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1111.0,"shares_display":"1,111","price_per_share":480.0,"price_display":"480.00","price_state":"stated","total_value":533280.0,"total_display":"533,280.00","total_whole":"533,280","shares_owned_after":45019.0,"shares_owned_after_display":"45,019","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-20","filed_date":"2025-02-24","scope":"insider"},{"id":2455435,"accession":"0000875320-24-000229","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000229","line_url":"/filing/0000875320-24-000229#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15.0,"shares_display":"15","price_per_share":478.56,"price_display":"478.56","price_state":"stated","total_value":7178.4,"total_display":"7,178.40","total_whole":"7,178","shares_owned_after":25813.0,"shares_owned_after_display":"25,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-15","filed_date":"2024-11-19","scope":"insider"},{"id":3245159,"accession":"0000875320-24-000150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000150","line_url":"/filing/0000875320-24-000150#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54.0,"shares_display":"54","price_per_share":430.93,"price_display":"430.93","price_state":"stated","total_value":23270.22,"total_display":"23,270.22","total_whole":"23,270","shares_owned_after":25813.0,"shares_owned_after_display":"25,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-17","scope":"insider"},{"id":2815889,"accession":"0000875320-24-000095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000095","line_url":"/filing/0000875320-24-000095#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4239.0,"shares_display":"4,239","price_per_share":425.7,"price_display":"425.70","price_state":"stated","total_value":1804542.3,"total_display":"1,804,542.30","total_whole":"1,804,542","shares_owned_after":25813.0,"shares_owned_after_display":"25,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-27","scope":"insider"},{"id":2078449,"accession":"0000875320-24-000085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000085","line_url":"/filing/0000875320-24-000085#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3002.0,"shares_display":"3,002","price_per_share":421.77,"price_display":"421.77","price_state":"stated","total_value":1266153.54,"total_display":"1,266,153.54","total_whole":"1,266,154","shares_owned_after":34022.0,"shares_owned_after_display":"34,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-21","filed_date":"2024-02-23","scope":"insider"},{"id":3198090,"accession":"0000875320-24-000066","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000875320-24-000066","line_url":"/filing/0000875320-24-000066#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4002.0,"shares_display":"4,002","price_per_share":420.79,"price_display":"420.79","price_state":"stated","total_value":1684001.58,"total_display":"1,684,001.58","total_whole":"1,684,002","shares_owned_after":37024.0,"shares_owned_after_display":"37,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-21","scope":"insider"},{"id":3149312,"accession":"0000875320-24-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000039","line_url":"/filing/0000875320-24-000039#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3145.0,"shares_display":"3,145","price_per_share":420.24,"price_display":"420.24","price_state":"stated","total_value":1321654.8,"total_display":"1,321,654.80","total_whole":"1,321,655","shares_owned_after":47588.0,"shares_owned_after_display":"47,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-13","scope":"insider"},{"id":7799320,"accession":"0000875320-23-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-23-000039","line_url":"/filing/0000875320-23-000039#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19.0,"shares_display":"19","price_per_share":369.92,"price_display":"369.92","price_state":"stated","total_value":7028.48,"total_display":"7,028.48","total_whole":"7,028","shares_owned_after":32038.0,"shares_owned_after_display":"32,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8388758,"accession":"0000899243-23-018044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-018044","line_url":"/filing/0000899243-23-018044#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63.0,"shares_display":"63","price_per_share":345.51,"price_display":"345.51","price_state":"stated","total_value":21767.13,"total_display":"21,767.13","total_whole":"21,767","shares_owned_after":32038.0,"shares_owned_after_display":"32,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-09","filed_date":"2023-08-11","scope":"insider"},{"id":8288524,"accession":"0001209191-23-013685","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-013685","line_url":"/filing/0001209191-23-013685","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4238.0,"shares_display":"4,238","price_per_share":287.50577630957997,"price_display":"287.51","price_state":"stated","total_value":1218449.48,"total_display":"1,218,449.48","total_whole":"1,218,449","shares_owned_after":32640.0,"shares_owned_after_display":"32,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-02-28","scope":"insider","n_lines":3},{"id":8182756,"accession":"0001209191-23-011655","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-011655","line_url":"/filing/0001209191-23-011655","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4002.0,"shares_display":"4,002","price_per_share":293.7721464267866,"price_display":"293.77","price_state":"stated","total_value":1175676.13,"total_display":"1,175,676.13","total_whole":"1,175,676","shares_owned_after":41146.0,"shares_owned_after_display":"41,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-21","filed_date":"2023-02-22","scope":"insider","n_lines":4},{"id":7809817,"accession":"0001209191-23-010045","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-010045","line_url":"/filing/0001209191-23-010045","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6398.0,"shares_display":"6,398","price_per_share":298.7039527977493,"price_display":"298.70","price_state":"stated","total_value":1911107.89,"total_display":"1,911,107.89","total_whole":"1,911,108","shares_owned_after":50194.0,"shares_owned_after_display":"50,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-16","scope":"insider","n_lines":6},{"id":7830349,"accession":"0001209191-23-009174","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-009174","line_url":"/filing/0001209191-23-009174","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4798.0,"shares_display":"4,798","price_per_share":298.9008920383493,"price_display":"298.90","price_state":"stated","total_value":1434126.48,"total_display":"1,434,126.48","total_whole":"1,434,126","shares_owned_after":56789.0,"shares_owned_after_display":"56,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-14","scope":"insider","n_lines":4},{"id":8461986,"accession":"0001209191-23-007827","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-23-007827","line_url":"/filing/0001209191-23-007827","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1304.0,"shares_display":"1,304","price_per_share":305.9982975460123,"price_display":"306.00","price_state":"stated","total_value":399021.78,"total_display":"399,021.78","total_whole":"399,022","shares_owned_after":68798.0,"shares_owned_after_display":"68,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-08","scope":"insider","n_lines":6},{"id":6915281,"accession":"0000899243-22-036184","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-036184","line_url":"/filing/0000899243-22-036184#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34.0,"shares_display":"34","price_per_share":308.61,"price_display":"308.61","price_state":"stated","total_value":10492.74,"total_display":"10,492.74","total_whole":"10,493","shares_owned_after":36077.0,"shares_owned_after_display":"36,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-17","scope":"insider"},{"id":6533601,"accession":"0000899243-22-035443","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-22-035443","line_url":"/filing/0000899243-22-035443","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1303.0,"shares_display":"1,303","price_per_share":303.03808902532614,"price_display":"303.04","price_state":"stated","total_value":394858.63,"total_display":"394,858.63","total_whole":"394,859","shares_owned_after":36300.0,"shares_owned_after_display":"36,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-07","filed_date":"2022-11-09","scope":"insider","n_lines":7},{"id":6167315,"accession":"0000899243-22-028246","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-028246","line_url":"/filing/0000899243-22-028246#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":424.0,"shares_display":"424","price_per_share":291.53,"price_display":"291.53","price_state":"stated","total_value":123608.72,"total_display":"123,608.72","total_whole":"123,609","shares_owned_after":36735.0,"shares_owned_after_display":"36,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-10","scope":"insider"},{"id":6167312,"accession":"0000899243-22-028246","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-028246","line_url":"/filing/0000899243-22-028246#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":302.0,"shares_display":"302","price_per_share":293.99,"price_display":"293.99","price_state":"stated","total_value":88784.98,"total_display":"88,784.98","total_whole":"88,785","shares_owned_after":36223.0,"shares_owned_after_display":"36,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-10","scope":"insider"},{"id":6167310,"accession":"0000899243-22-028246","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-028246","line_url":"/filing/0000899243-22-028246#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":222.0,"shares_display":"222","price_per_share":290.32,"price_display":"290.32","price_state":"stated","total_value":64451.04,"total_display":"64,451.04","total_whole":"64,451","shares_owned_after":37159.0,"shares_owned_after_display":"37,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-10","scope":"insider"},{"id":6167304,"accession":"0000899243-22-028246","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-028246","line_url":"/filing/0000899243-22-028246#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001550395","owner_name":"ALTSHULER DAVID","owner_display_name":"ALTSHULER DAVID","owner_url":"/insider/0001550395","role":"Officer (EVP, Global Research and CSO)","role_mark":"O","role_mark_label":"Officer (EVP, Global Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Research and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":210.0,"shares_display":"210","price_per_share":293.02,"price_display":"293.02","price_state":"stated","total_value":61534.2,"total_display":"61,534.20","total_whole":"61,534","shares_owned_after":36525.0,"shares_owned_after_display":"36,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-10","scope":"insider"}],"collapsed":true,"next_cursor":"2022-08-08|6167304","ledger_fault":false,"count":{"value":229,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":229,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":229},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Director, Officer (EVP, Chief Scientific Officer)","n_filings":89,"first_seen":"2014-08-01","last_seen":"2025-05-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001550395","retrieved_at":"2026-08-25T16:02:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}